Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation

NCT02172508 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium Inhalation Capsule
DRUG: Placebo Lactose Capsule

Sponsor

Boehringer Ingelheim